Entry |
|
Name |
Nelipepimut-S (USAN); Neuvax |
Formula |
C50H78N10O11
|
Exact mass |
994.5852
|
Mol weight |
995.2147
|
Efficacy |
Antineoplastic, Receptor tyrosine kinase inhibitor |
Comment |
Cancer immunotherapy for prevention and delay of cancer recurrence
|
Target |
|
Brite |
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
EGFR family
ERBB2 (HER2, CD340)
D10344 Nelipepimut-S (USAN)
|
Other DBs |
|